A Study of RO6885247 in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH)
Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This multicenter, randomized, double-blind, 12-week, placebo-controlled multiple dose study
will investigate the safety and tolerability of RO6885247 in adult and pediatric patients
with spinal muscular atrophy (SMA).